Skip to content

TURP for men on blood thinners or with a catheter

What the studies show about TURP in men on anticoagulant or antiplatelet drugs and in men who have a catheter because of urinary retention.

Dr. Petronio Melo, urologistA reference in enlarged prostate (BPH) treatment
CRM-SP 157.598 · RQE 70.275
Reviewed by Dr. Petronio Melo on November 15, 2026
Book a consultation
Front-view drawing of the bladder and the enlarged prostate, with a catheter running through the urethra and the balloon inside the bladder
On this page

Quick answer

TURP can be done in men who take anticoagulant or antiplatelet drugs, but staying on the medication increases the risk of bleeding.2 In my practice, I stop the medication whenever possible, always together with the doctor who prescribed it. When it cannot be stopped, we look at the options together. Men who have a catheter because of urinary retention can also have surgery: in a study of 379 men, only 1% needed a long-term catheter after TURP.11

Anticoagulants and antiplatelet drugs

These medications thin the blood and protect the heart and brain from clots. Antiplatelet drugs, such as aspirin and clopidogrel, act on the platelets. Anticoagulants act on clotting: warfarin is the oldest, and the newer anticoagulants include rivaroxaban, apixaban and dabigatran.

In TURP, a loop with energy cuts the prostate tissue into small pieces and controls bleeding at the same time.1 These medications make that control harder, during and after surgery.

The risk of bleeding with TURP

In a 2026 review of 15 studies with 6,091 men, those who stayed on an anticoagulant or antiplatelet drug during surgery had more bleeding complications after TURP and a slightly longer hospital stay. The drop in hemoglobin and the catheter time were similar to those of men who did not take these medications.2

The type of medication matters. In a Swiss study of bipolar TURP, men who stayed on aspirin had results similar to those of men who took no such medication. With clopidogrel and with an anticoagulant from the same family as warfarin, the risk of bleeding rose and the hospital stay was longer.3 In my practice, I assess aspirin case by case.

StudyPatientsResult
Switzerland, 2019276 men operated on without stopping the medication, 73 not on these medicationsNo difference with aspirin; with clopidogrel, transfusion in 19%, versus 1%; with an anticoagulant from the same family as warfarin, catheter for 42 hours, versus 24, and retention after surgery in 18%, versus 6%3
Turkey, 2025Men who had TURP, with and without these medicationsClots blocking the urine in 7.6%, versus 0.5%, and readmission for blood in the urine in 11.4%, versus 3.7%4
Germany, 2021221 men staying on the medication, 110 with TURP and 111 with HoLEPHemoglobin drop of 2.2 with TURP and 0.7 with HoLEP; adverse events in 16.4% and 5.4%5

Bipolar TURP tends to bleed a little less than monopolar TURP. A Cochrane review estimated 28 fewer transfusions for every 1,000 men treated with the bipolar form.6

The European guideline summarizes the Swiss study of bipolar TURP in these men.1 For men on anticoagulant or antiplatelet drugs, it recommends offering laser vaporization, such as Greenlight, in prostates smaller than 80 g, and thulium laser enucleation, both as weak recommendations. It also describes holmium laser enucleation, HoLEP, as done safely in this group.1 In practice, prostate size and technique have to be assessed case by case.

Stopping the medication before TURP

In my practice, I stop the anticoagulant or antiplatelet drug whenever possible, always together with the cardiologist or the other doctor who prescribed it.

The review by the American Urological Association and the International Consultation on Urological Diseases points out that stopping or changing these medications without a plan can lead to serious complications in people who had a recent thrombosis or who have a mechanical valve, atrial fibrillation or a heart stent. It also advises postponing surgery that can wait when it would require stopping both antiplatelet drugs in someone who had a stent placed a short time ago.7

How long to pause depends on the medication. In a study of 3,007 people with atrial fibrillation, the newer anticoagulants were stopped a few days before surgery, according to the drug, the bleeding risk and kidney function, without heparin injections. Major bleeding and clots in the arteries, such as stroke, stayed at low rates.8

Heparin injections in place of the medication, known as bridging, do not always help. In a study of 1,884 people with atrial fibrillation who stopped warfarin, going without bridging protected just as well against clots in the arteries, such as stroke, and led to less major bleeding, 1.3% versus 3.2%.9 At an Australian center, men who had heparin bridging for TURP bled in 44% of cases, versus 8% of men who did not take these medications.10 For this reason, bridging is decided case by case by the doctor who manages the medication.

Restarting the medication after surgery is also agreed with that doctor. The recommendation is to restart it as soon as the risk of bleeding goes down.7

When the medication cannot be stopped

Some people cannot stop the medication even for a few days. In these cases, we look at the options together.

In my practice, Greenlight is done without stopping the anticoagulant, and HoLEP is possible even in men who take an anticoagulant. In the 2026 review, staying on these medications did not increase transfusion or surgery to stop bleeding after Greenlight, and the authors suggest vaporization as the preferred technique for men who need to stay on the medication without a pause.2 In the German study of pairs of similar men, all staying on the medication, HoLEP bled less than TURP.5

The details of each technique are in Greenlight for men on blood thinners or with a catheter and in HoLEP for men on blood thinners or with a catheter.

For men with a catheter because of retention

Urinary retention means the bladder cannot empty. It can be acute, when the urine stops suddenly, or chronic, when the bladder fills up little by little.

At a London hospital, 379 men had TURP. When the catheter was first removed, 10% of those with acute retention, 38% of those with chronic retention and 44% of those with acute-on-chronic retention could not urinate. All the men operated on for symptoms alone urinated. Even so, only 1% of the 379 men needed a long-term catheter.11

At a British center, 147 men aged 80 or older, all with a catheter because of chronic retention, had TURP. At 3 months, 80.3% had no indwelling catheter or were using intermittent catheterization, done by the patient himself. At 1 year, 79.6% remained catheter-free. More than 1,500 mL of urine left in the bladder before surgery and age 90 or older increased the chance that it would not work.12

How I approach it

I have performed TURP since 2015, both monopolar and bipolar. In my practice, anesthesia is general or spinal, and the catheter and the hospital stay last 1 to 2 days. You go back to work and to driving after 14 days, and to sex and heavy activity after 1 month. In a German study of 10,654 men, 5.8% had difficulty urinating when the catheter was removed.16

Before recommending surgery, I look at which medications you take, why you take them and how long you have had a catheter, and I compare TURP with the other techniques. In men who take an anticoagulant, I stop the medication whenever possible, together with the doctor who prescribed it. Retrograde ejaculation, in which semen goes into the bladder, is very common after TURP.1 See what changes in ejaculation and erections, and how the surgery is done in TURP.

When to see a urologist

  • If you take an anticoagulant or antiplatelet drug and need prostate surgery
  • If you were told you would need to stop the medication to have surgery
  • If you have a catheter because of your prostate
  • After surgery, if the urine has clots or stops coming out

Send your case

If you take blood thinners or have a catheter and would like my opinion on your case before a consultation, fill in the form below. Tell me which medications you use and how long you have had the catheter. It goes to my office, and you will get a reply within 24 hours by email or WhatsApp. The form does not replace a consultation: it helps plan the next step.

Frequently asked questions

Can men on blood thinners have TURP?

Yes, but staying on the medication increases the risk of bleeding. In a review of 15 studies with 6,091 men, those who stayed on an anticoagulant or antiplatelet drug had more bleeding complications after TURP.2 In my practice, I stop the medication whenever possible, together with the doctor who prescribed it.

Do I need to stop my blood thinner before TURP?

In my practice, I stop it whenever possible. The decision is made together with the cardiologist or the other doctor who prescribed the medication, because stopping it without a plan can bring a risk of thrombosis, especially in people with a heart stent, a mechanical valve or an arrhythmia.7

What if I cannot stop the medication?

We look at the options together. In my practice, Greenlight is done without stopping the anticoagulant, and HoLEP is possible even in men who take an anticoagulant. In the 2026 review, staying on the medication did not increase bleeding after Greenlight.2

Does aspirin also increase bleeding with TURP?

In a Swiss study of bipolar TURP, men who stayed on aspirin had results similar to those of men who did not take these medications. With clopidogrel, transfusion was 19%, versus 1%.3 In my practice, I assess aspirin case by case, like every medication.

Will I need heparin injections instead of my anticoagulant?

It depends on why you take the medication, and that decision belongs to the doctor who prescribed it. In a study of 1,884 people with atrial fibrillation who stopped warfarin, going without the injections protected just as well against clots in the arteries, such as stroke, and led to less major bleeding, 1.3% versus 3.2%.9

I have a catheter because of urinary retention. Will TURP solve it?

In most cases, yes. In a study of 379 men, some of those in retention could not urinate when the catheter was first removed, but only 1% of all the men needed a long-term catheter.11 Among 147 men aged 80 or older, 79.6% were catheter-free 1 year after TURP.12

What if my bladder is weak?

The improvement tends to be smaller at first, but surgery can still help. In a review of 3,694 men, complications were similar, and after 12 months symptoms were similar to those of men with a normal bladder.14 When the bladder does not contract, the chance of becoming catheter-free is lower.15

How long will I have a catheter after TURP?

In my practice, the catheter and the hospital stay last 1 to 2 days, and the catheter is removed before you go home. In a German study of 10,654 men, 5.8% had difficulty urinating when the catheter was removed.16

Who performs TURP in São Paulo?

I am Dr. Petronio Melo, a urologist and robotic surgeon in São Paulo, CRM-SP 157.598 and RQE 70.275. I have performed TURP since 2015, both monopolar and bipolar. In men who take an anticoagulant, I stop the medication whenever possible, together with the doctor who prescribed it. My office is in Vila Mariana, and the first consultation can be in person or online, in English.

References

  1. EAU Guidelines on the Management of Non-neurogenic Male LUTS. European Association of Urology; 2026. Disease management chapter. EAU
  2. Giulioni C, Cafarelli A, Falsetti F, et al. Perioperative outcomes of ongoing antithrombotic therapy during endoscopic surgery for benign prostatic hyperplasia: a systematic review and meta-analysis of observational studies. Prostate Cancer Prostatic Dis. 2026;29(4):735-753. PubMed
  3. Rühle A, Blarer J, Oehme F, et al. Safety and effectiveness of bipolar transurethral resection of the prostate in patients under ongoing oral anticoagulation with coumarins or antiplatelet drug therapy compared to patients without anticoagulation/antiplatelet therapy. J Endourol. 2019;33(6):455-462. PubMed
  4. Ilktac A, Ersoz C, Kalkan S, et al. Bleeding risks in urologic surgery: a prospective analysis of anticoagulant and antiaggregant use in transurethral resection of prostate, transurethral resection of bladder tumour and open prostatectomy. Arch Esp Urol. 2025;78(10):1392-1400. PubMed
  5. Westhofen T, Schott M, Keller P, et al. Superiority of holmium laser enucleation of the prostate over transurethral resection of the prostate in a matched-pair analysis of bleeding complications under various antithrombotic regimens. J Endourol. 2021;35(3):328-34. PubMed
  6. Alexander CE, Scullion MM, Omar MI, et al. Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction. Cochrane Database Syst Rev. 2019;12(12):CD009629. PubMed
  7. Culkin DJ, Exaire EJ, Green D, et al. Anticoagulation and antiplatelet therapy in urological practice: ICUD/AUA review paper. J Urol. 2014;192(4):1026-34. PubMed
  8. Douketis JD, Spyropoulos AC, Duncan J, et al. Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant. JAMA Intern Med. 2019;179(11):1469-1478. PubMed
  9. Douketis JD, Spyropoulos AC, Kaatz S, et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med. 2015;373(9):823-33. PubMed
  10. Ong WL, Koh TL, Fletcher J, et al. Perioperative management of antiplatelets and anticoagulants among patients undergoing elective transurethral resection of the prostate: a single institution experience. J Endourol. 2015;29(11):1321-7. PubMed
  11. Reynard JM, Shearer RJ. Failure to void after transurethral resection of the prostate and mode of presentation. Urology. 1999;53(2):336-9. PubMed
  12. Antoniou V, Edris F, Akpobire W, et al. Surgical outcomes for elderly patients undergoing transurethral resection of the prostate for chronic urinary retention and proposal of a management algorithm. J Endourol. 2023;37(5):581-586. PubMed
  13. Kim M, Jeong CW, Oh SJ. Effect of preoperative urodynamic detrusor underactivity on transurethral surgery for benign prostatic hyperplasia: a systematic review and meta-analysis. J Urol. 2018;199(1):237-244. PubMed
  14. Wroclawski ML, Takemura LS, Santos HOD, et al. Functional and safety outcomes after benign prostatic enlargement surgeries in men with detrusor underactivity compared with normal detrusor contractility: systematic review and meta-analysis. Neurourol Urodyn. 2024;43(1):126-143. PubMed
  15. Kenyeres B, Helmeczi A, Pytel Á. Efficacy of transurethral resection of the prostate in male patients with impaired detrusor contractile function and urinary retention. Low Urin Tract Symptoms. 2025;17(6):e70040. PubMed
  16. Reich O, Gratzke C, Bachmann A, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008;180(1):246-9. PubMed

Would you like to talk about your case?

In the consultation, I go over your tests and your priorities.

Book a consultation5.0186 Google reviews

Related guides